1. Alkushi A, Köbel M, Kalloger SE, Gilks CB (2010) High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes. Int J Gynecol Pathol 29(4):343–350
2. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I (2005) Endometrial cancer. Lancet 366(9484):491–505
3. Ambros RA, Sheehan CE, Kallakury BV, Ross JS, Malfetano J, Paunovich E, Figge J (1996) MDM2 and p53 protein expression in the histologic subtypes of endometrial carcinoma. Mod Pathol 9(12):1165–1169
4. Arora N (2020) Hereditary endometrial cancers. In: Mehta S, Gupta B (eds) Recent advances in endometrial cancer. Springer, Singapore, pp 77–95
5. Banno K, Yanokura M, Susumu N, Kawaguchi M, Hirao N, Hirasawa A, Tsukazaki K, Aoki D (2006) Relationship of the aberrant DNA hypermethylation of cancer-related genes with carcinogenesis of endometrial cancer. Oncol Rep 16(6):1189–1196